Hi {{lead.First Name:default=edit me}},

You know that human biospecimens represent the best research model, but accessing the right human samples can be challenging. Fortunately, Astellas's pipeline matches well with Sanguine’s network of highly characterized, recallable patient donors, so you can choose I/E criteria, obtain PROs, and timely receive the right samples, including PBMCs and leukopaks. Search Sanguine's nationwide donor network, which includes:

  • >13,000 donors with immunology indications, our most diverse patient group
  • >2,000 donors with oncology conditions, including leukemia and prostate cancer
  • >800 donors with rare disease, with a growing community of patient advocacy groups

Astellas's commitment to treating inflammatory conditions and Sanguine's goal of connecting patients to researcher explains why our companies have partnered on 6 so far. Let’s discuss whether we can continue succeeding for patients.

Warm Regards,

Alyssa Cook
Research Consultant
Sanguine Bio | Massachusetts

Schedule a Meeting
| www.sanguinebio.com